You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | n/a |
| Div Cover | n/a | n/a |
| Op Mrgn | 0.0% | n/a |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -1.3 | n/a |
| PEG | 0.0 | n/a |
| Price / Revenue | 0.0 | n/a |
| Price / Book value | 0.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (€m) |
Pre-tax (€m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | n/a | -2.00 | €-0.02 | -4.1 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | n/a | -1.90 | €-0.02 | -7.6 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | n/a | -2.32 | €-0.03 | -3.6 | 0.0 | n/a | n/a | 0.0% |
| 2021-12-31 | n/a | -5.25 | €-0.06 | -2.7 | 0.0 | n/a | n/a | 0.0% |
| Ovoca Bio to dispose of Russian assets Sharecast News | 08 Mar |
|---|---|
| Ovoca Bio enrols participants in women's sexual drug trial Sharecast News | 29 Jul |
| Price Monitoring Extension | 16-Mar-23 23:59 |
|---|---|
| Second Price Monitoring Extn | 16-Mar-23 23:52 |
| Price Monitoring Extension | 16-Mar-23 23:47 |
| Second Price Monitoring Extn | 16-Mar-23 18:03 |
| Price Monitoring Extension | 16-Mar-23 17:57 |